Press Release Ocugen Announces that the U.S. Food and Drug Administration Has Granted OCU410 Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Geographic Atrophy, Secondary to Dry Age-Related Macular Degeneration Ocugen · Jul 29
Press Release Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET Aquestive Therapeutics, Inc. · Jul 29
Press Release uniQure Announces Second Quarter 2026 Financial Results and Provides Company Update uniQure Inc. · Jul 29
Press Release Teva Delivers Strong Q2 Results and Raises Outlook for All Three Key Innovative Brands, Reflecting Continued Execution of Its Pivot to Growth Strategy Teva Pharmaceutical Industries Ltd · Jul 29
Press Release Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe Ceribell · Jul 29
Press Release TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2™, a Pivotal Trial Evaluating TSC-101 in Patients with Heme Malignancies TScan Therapeutics, Inc. · Jul 29
Press Release Energous’ PowerBridge Pro+ Receives FCC Certification, Advancing Commercialization of the Company’s End-to-End Wireless Power Solution Energous · Jul 29
Press Release Interest in Disability Insurance for Veterinarians Triples in 12 Months Set for Life Insurance · Jul 29
Press Release PENSKE AUTOMOTIVE GROUP REPORTS QUARTERLY RESULTS Penske Automotive Group, Inc. · Jul 29
Press Release Triquetra Health Launches Mental Magnesium™ — First Dual-Pathway Brain Formula Combining Patented BBB-Crossing Magtein® with ATA Mg® Neural Excitation Control Triquetra Health LLC · Jul 29
Press Release BANKFIRST CAPITAL CORPORATION Reports Second Quarter 2026 Earnings of $8.66 Million BankFirst Capital Corporation · Jul 29
Press Release UPDATE: HIGHWAY HOLDINGS UPDATES RECORD DATE FOR US$0.05 CASH DIVIDEND PER SHARE Highway Holdings Limited · Jul 29